Search

After the 2018 General Election, the incoming coalition made numerous institutional reform pledges, including the establishment of a Malaysian media council to self-govern the press. Nevertheless, the concept is not new as it was initially proposed in 1973. Following stakeholders' discussions over the past few years, it was decided that a self-regulatory media council should be formed. This is a critical step towards restoring the country's long-suffering press freedom that had been stifled by press regulations. Hence, it is necessary to study the self-regulatory paradigm as Malaysia is moving towards the formation of a self-regulatory media council to govern its press. The United Kingdom's vast experience with media self-regulation may help Malaysian policymakers decide whether to adopt a self-regulatory approach to governance or not. The authors in this study used textual analysis of legislation and case law and secondary data from existing works to examine the proposal of establishing a self-regulatory Malaysian media council. [ABSTRACT FROM AUTHOR]

Summary: Background: Late‐night supper increases the risk of postprandial reflux from the acid pocket especially in obesity. An alginate‐based, raft‐forming medication may be useful for obese patients with GERD. Aims: To compare the efficacy of Gaviscon Advance (Reckitt Benckiser, UK) and a non‐alginate antacid in post‐supper suppression of the acid pocket and post‐prandial reflux among obese participants. Methods: Participants underwent 48 h wireless and probe‐based pH‐metry recording of the acid pocket and lower oesophagus, respectively, and were randomised to single post‐supper (10 pm) dose of either Gaviscon Advance or a non‐alginate antacid on the second night. Primary outcomes were suppression of median pH of acid pocket and lower oesophagus, measured every 10‐minutes post‐supper for 1 h. Secondary outcomes were suppression of % time pH < 4 at lower oesophagus and improvement in frequency and visual analogue score (VAS) of regurgitation. Results: Of the 81 screened participants, 55 were excluded and 26 (mean age 33.5 years, males 77.8% and BMI 32.8 kg/m2) were randomised to Gaviscon Advance (n = 13) or antacid (n = 13). Median pH of the acid pocket but not the lower oesophagus was suppressed with Gaviscon Advance vs antacid (all P < 0.04) Gaviscon Advance but not antacid significantly reduced in % time pH < 4, symptom frequency and VAS on day 2 vs day 1 (all P < 0.05). Conclusions: Among obese individuals, Gaviscon Advance was superior to a non‐alginate antacid in post‐supper suppression of the acid pocket. (Clinical trial registration unique identifier: NCT03516188). [ABSTRACT FROM AUTHOR]